However, in a setting of slowly evolving CNS damage, such as the pathology underlying dementias, GFAP-C6 serum levels might show diagnostic and/or prognostic abilities by reflecting processes affected by CNS injury, as suggested in this study. This evidence concerns the gene GFAP and dementia.